Ligand profile
RAH
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00004 — Ribokinase
Identifiers
Database identifiers and provenance.
- Ligand ID
RAH- PDB
7agk- UniProt (similar protein)
P32143- Target protein
- KP13_00004
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 191.0
- −1 ≤ LogP ≤ 5 -3.21
- MW ≤ 500 Da 324.2
- LogP ≤ 5 -3.21
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 191.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C([C@@H]1[C@H]([C@@H]([C@](O1)(COP(=O)(O)O)O)O)O)S(=O)(=O)OC([C@@H]1[C@H]([C@@H]([C@](O1)(COP(=O)(O)O)O)O)O)S(=O)(=O)O
InChI=1S/C6H13O11PS/c7-4-3(1-19(13,14)15)17-6(9,5(4)8)2-16-18(10,11)12/h3-5,7-9H,1-2H2,(H2,10,11,12)(H,13,14,15)/t3-,4-,5+,6-/m1/s1InChI=1S/C6H13O11PS/c7-4-3(1-19(13,14)15)17-6(9,5(4)8)2-16-18(10,11)12/h3-5,7-9H,1-2H2,(H2,10,11,12)(H,13,14,15)/t3-,4-,5+,6-/m1/s1
IZVMCURFIBVEOJ-ARQDHWQXSA-NIZVMCURFIBVEOJ-ARQDHWQXSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00294
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand RAH →
- PDB RCSB structure 7agk →
- UniProt UniProt P32143 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “RAH”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00004.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).